CIE-10

CIE-10-código D35

You are here: Inicio > CIE-10 > C00-D49 > D10-D36

- CIE-10
Clasificación Internacional de Enfermedades
- C00-D49
Tumores [neoplasias]
- D10-D36
Tumores [neoplasias] benignos

D35

Tumor benigno de otras glándulas endocrinas y de las no especificadas

CIE-10 Сódigo D35 para Tumor benigno de otras glándulas endocrinas y de las no especificadas

Excluye: ovario (D27)

páncreas endocrino (D13.7)

testículo (D29.2)

timo (D15.0)

D35.0
Tumor benigno de la glándula suprarrenal
D35.1
Tumor benigno de la glándula paratiroides
D35.2
Tumor benigno de la hipófisis
D35.3
Tumor benigno del conducto craneofaríngeo
D35.4
Tumor benigno de la glándula pineal
D35.5
Tumor benigno del cuerpo carotídeo
D35.6
Tumor benigno del cuerpo aórtico y de otros cuerpos cromafines
D35.7
Tumor benigno de otras glándulas endocrinas especificadas
D35.8
Tumor benigno pluriglandular
D35.9
Tumor benigno de glándula endocrina no especificada
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us